Fresenius | FRE - Gross Profit On Sales


Fresenius reported EUR1.55B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Akzo Nobel EUR 978M 42M Mar/2026
Alcon AG USD 1.69B 175M Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
BASF EUR 4.33B 181M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Beiersdorf EUR 1.54B 1.16B Jun/2025
DaVita Healthcare Partners USD 895.46M 128.1M Mar/2026
Demant DKK 8.82B 277M Dec/2025
E.ON EUR 5.41B 672M Mar/2026
Essilor EUR 9.41B 1.12B Jun/2026
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Getinge SEK 4.42B 638M Jun/2026
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GN Store Nord DKK 2.5B 344M Dec/2025
GRIFOLS EUR 704M 84M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Philips EUR 2.15B 384M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
RWE EUR 2.74B 2.02B Dec/2025
Sanofi EUR 8.71B 602M Jun/2026
Smith & Nephew USD 2.09B 117M Dec/2025